Site updated at Wednesday, 22 June 2016

Living with Dementia


Sanofi to test Parkinson’s drug with Michael J. Fox Foundation

French drugmaker Sanofi said on Thursday it would collaborate with the Michael J. Fox Foundation to test an early- stage experimental treatment for Parkinson’s disease.

Under the terms of the collaboration, MJFF will sponsor a phase I clinical trial to study the safety and tolerability of Sanofi’s AVE8112, a drug that has shown promise… Sanofi to test Parkinson’s drug with Michael J. Fox Foundation   

What is dementia?

hd patients1 - lewy bodies2 - korsakoff's syndrome10 - alzheimer's population1 - cognitive symptoms1 - brain health1 - mild tbi1 - semantic dementia1 - amyloid markers1 - gene therapy1 - hiv1 - management of delirium1 - development of parkinson's1 - karl wernicke4 - alzheimer's prevention1 - neurofibrillary tangles3 - hallucinoses1 - senility1 - cognitive deficits1 - ad prognosis1 - atherosclerosis7 - university of gothenburg1 - treatment for huntington disease1 - cerebral parenchyma1 - amyloid beta peptide1 - preventing alzheimer's1 - functional psychosis1 - amyloid-β1 - risk of alzheimer's3 - microrna1 -